FDA Inspection 1269240 — Vitalant

Vitalant — FEI 2077574

The FDA completed an inspection of Vitalant on April 30, 2025 in Ventura, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 30, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ventura, CA (United States)